ESGO 2023 Insights: "CA125 Kinetics - KELIM to Help Select Ovarian Cancer Patients for Treatment With Bevacizumab and Potentially PARPi"

166 views
October 11, 2023
0 Comments
Login to view comments. Click here to Login